EMR PEG Ratio Analysis

The PEG ratio, or price/earnings-to-growth ratio, measures a stock’s price relative to its expected earnings growth — a value of 1.19x means the stock is priced at 1.19 times its projected annual growth rate.

This is slightly above the sector median of 0.97x, placing EMR in the 55th percentile among peers, indicating a modest premium versus the typical peer. The metric has been decreasing over the last eight quarters, with no year-over-year change available and a quarter-over-quarter decline of -0.8%. A level above the sector median suggests investors are paying a higher multiple for growth, while the declining trend could signal that the valuation premium is narrowing, potentially reducing risk if earnings growth holds. Taken together, the combination of a slight premium and a downward trend implies a neutral risk/opportunity profile — the stock is not clearly undervalued nor overvalued. This directly supports the overall NEUTRAL verdict, as the PEG ratio neither strongly contradicts nor reinforces a bullish or bearish stance.

Frequently Asked Questions

Closest Sector Peers